Press release
Leading Growth Driver in the Nontuberculous Mycobacterial Infection Market in 2025: Rising Prevalence Of Copd Fuels Growth In The Nontuberculous Mycobacterial Infection Market Driver's Influence
Nontuberculous Mycobacterial Infection Market Growth
The nontuberculous mycobacterial infection market has demonstrated strong growth in recent years. It is expected to grow from $14.25 billion in 2024 to $15.11 billion in 2025, at a CAGR of 6.0%. This expansion has been driven by advancements in diagnostic techniques, a growing aging population, increased awareness of cystic fibrosis, and the use of immunosuppressive medications.
The nontuberculous mycobacterial infection market is projected to see strong growth, reaching $19.57 billion by 2029, growing at a CAGR of 6.7%. The growth is driven by antimicrobial drug development, greater awareness of NTM, advances in genetic research, and the adoption of telehealth and remote monitoring. Major trends include personalized treatments, regulatory focus, combination therapies, and digital health tools.
What Is Contributing to the Growth of the Nontuberculous Mycobacterial Infection Market?
The increasing occurrence of chronic obstructive pulmonary disease (COPD) is projected to accelerate the expansion of the nontuberculous mycobacterial infection market. COPD is a persistent respiratory disease that results in progressive airflow limitation in the lungs. Patients with COPD who develop nontuberculous mycobacterial (NTM) infections experience a greater decline in forced expiratory volume in one second (FEV1) and a higher rate of exacerbations. COPD weakens the immune system and causes lung tissue damage, making individuals more susceptible to NTM infections. For example, in March 2023, the Scottish Public Health Observatory (ScotPHO), a Scotland-based public health organization, published a report indicating that COPD rates increased between 2021 and 2022. Among males, the rates rose from 83.2 to 97.6 per 100,000 individuals, while female rates climbed from 72.6 to 97.3 per 100,000. Therefore, the rising prevalence of COPD is propelling the growth of the nontuberculous mycobacterial infection market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13020&type=smp
Which Key Market Leaders Are Driving Nontuberculous Mycobacterial Infection Industry Growth?
Major companies operating in the nontuberculous mycobacterial infection market are Pfizer Inc., Johnson & Johnson, F. Hoffman La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Lupin Limited, BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals Inc., Insmed Incorporated, Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Aradigm Corporation, Dauntless Pharmaceuticals Inc., Validus Pharmaceuticals LLC.
What Are the Emerging Trends in the Nontuberculous Mycobacterial Infection Industry?
Prominent companies in the nontuberculous mycobacterial (NTM) infection market are adopting regulatory strategies, such as Fast Track designation, to expedite drug approval processes and strengthen their market presence. The FDA's Fast Track designation accelerates the development and review of drugs designed to treat serious conditions with unmet medical needs. For example, in July 2022, the U.S. Food and Drug Administration granted Fast Track Designation to NUZYRA for the treatment of NTM lung disease caused by Mycobacterium avium complex (MAC). NUZYRA (omadacycline) is a broad-spectrum antibiotic designed to combat severe bacterial infections, including those resistant to conventional treatments. This designation streamlines the regulatory process, facilitating the rapid development and approval of NUZYRA to address significant unmet medical needs.
What Are the Main Segments in the Nontuberculous Mycobacterial Infection Market?
The nontuberculous mycobacterial infection market covered in this report is segmented -
1) By Drug Class: Macrolides, Rifampin, Aminoglycoside, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Other Routes
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Macrolides: Azithromycin, Clarithromycin
2) By Rifampin: Rifampin, Rifabutin
3) By Aminoglycoside: Amikacin, Streptomycin
4) By Other Drug Classes: Ethambutol, Clofazimine, Linezolid
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/nontuberculous-mycobacterial-infection-global-market-report
Which Geographic Area Leads the Nontuberculous Mycobacterial Infection Market?
North America was the largest region in the nontuberculous mycobacterial infection market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in nontuberculous mycobacterial infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Nontuberculous Mycobacterial Infection Global Market Report?
- Market Size Analysis: Analyze the Nontuberculous Mycobacterial Infection Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Nontuberculous Mycobacterial Infection Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Nontuberculous Mycobacterial Infection Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Nontuberculous Mycobacterial Infection Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13020
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Nontuberculous Mycobacterial Infection Market in 2025: Rising Prevalence Of Copd Fuels Growth In The Nontuberculous Mycobacterial Infection Market Driver's Influence here
News-ID: 3853018 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Nontuberculous
Rising Prevalence Of Copd Fuels Growth In The Nontuberculous Mycobacterial Infec …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
What Is the Expected CAGR for the Nontuberculous Mycobacterial Infection Market Through 2025?
There has been a substantial expansion in the market size for nontuberculous mycobacterial infection in the recent past. The market, which is projected to increase from $14.25 billion in 2024 to $15.11 billion in 2025, is…
Rising Prevalence Of Copd Fuels Growth In The Nontuberculous Mycobacterial Infec …
The Nontuberculous Mycobacterial Infection Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Nontuberculous Mycobacterial Infection Market Size and Projected Growth Rate?
The market size for nontuberculous mycobacterial infection has experienced robust growth in the past few years. The market that was valued at…
Nontuberculous Mycobacteria Market Growth and Key Innovations | 2025 To 2034 Sta …
On April 23, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Nontuberculous Mycobacteria Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Nontuberculous Mycobacteria Market Projected to Show Strong Growth
Pro Market Reports published a new research publication on "Nontuberculous Mycobacteria Market" with 230+ pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Nontuberculous Mycobacteria market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in the study are:…
Nontuberculous Mycobacterial Infection Market 2024 - By Size, Industry Analysis, …
The new report published by The Business Research Company, titled Nontuberculous Mycobacterial Infection Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion…
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications.
The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few…
